Attached files
| file | filename |
|---|---|
| EX-99.3 - EX-99.3 - Amneal Pharmaceuticals, Inc. | d905579dex993.htm |
| EX-99.2 - EX-99.2 - Amneal Pharmaceuticals, Inc. | d905579dex992.htm |
| EX-99.1 - EX-99.1 - Amneal Pharmaceuticals, Inc. | d905579dex991.htm |
| EX-23.1 - EX-23.1 - Amneal Pharmaceuticals, Inc. | d905579dex231.htm |
| 8-K/A - 8-K/A - Amneal Pharmaceuticals, Inc. | d905579d8ka.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT AUDITOR
We consent to the incorporation by reference in the Registration Statement No. 333-224700 on Form S-8 and No. 333-230022 and 333-224702 on Form S-3 of Amneal Pharmaceuticals, Inc. of our report dated April 17, 2020 on the financial statements of Dixon-Shane LLC dba R&S Northeast, LLC which is included in this Current Report Amendment No. 1 on Form 8-K/A.
/s/ Crowe LLP
Franklin, Tennessee
April 17, 2020